New South Wales, Australia

Jonathan Morris

This inventor holds 9 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Exonate Limited, Newsouth Innovations Pty Limited, University of Nottingham. Active years: 2017-2025.

USPTO Granted Patents = 9 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • New South Wales, AU (2017 - 2019)
  • Sydney, AU (2020 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jonathan Morris

Introduction

Jonathan Morris is a notable inventor based in New South Wales, Australia. He has made significant contributions to the field of anti-angiogenic treatments, with a focus on various medical applications. His innovative work has led to the development of several patents that address critical health issues.

Latest Patents

Jonathan Morris holds 9 patents that showcase his expertise in medical treatments. His latest patents include SRPK1 inhibitors, which are designed for anti-angiogenic treatments. These treatments target conditions such as ocular neovascularization and cancer, as well as hyperpermeability disorders, neuropathic and neurodegenerative disorders, and pain management. Additionally, he has developed 1-methyl-1H-pyrazol-3-yl derivatives for use in treating neovascular diseases. These compounds are particularly effective in addressing conditions associated with abnormal angiogenesis and the over-production of pro-angiogenic VEGF isoforms in the eye.

Career Highlights

Throughout his career, Jonathan has worked with reputable organizations, including Newsouth Innovations Pty Limited and the University of Nottingham. His work in these institutions has allowed him to further his research and development in the field of medical innovations.

Collaborations

Jonathan has collaborated with esteemed colleagues such as David Owen Bates and Andrew Douglas Baxter. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jonathan Morris is a distinguished inventor whose work in anti-angiogenic treatments has made a significant impact on medical science. His numerous patents reflect his dedication to improving health outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…